List of insiders holdings for SpringWorks Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GORDON CARL L Director 10% Owner | 2019-09-12 16:28:35 | 0 7,131,307 | 7,131,307 | Form 3 |
| SQUINTO STEPHEN P Director 10% Owner | 2022-05-20 17:44:52 | 146,970 6,186,307 | 6,333,277 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 2023-12-06 16:43:33 | 3,567,159 0 | 3,567,159 | Form 13D |
| Schwartz Jeffrey Lawrence Director | 2023-05-25 17:04:48 | 24,346 3,081,307 | 3,105,653 | Form 4 |
| Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 2023-03-20 17:01:57 | 3,081,307 0 | 3,081,307 | Form 13D |
| PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 2022-02-11 19:01:39 | 2,340,330 0 | 2,340,330 | Form 13G |
| Islam Saqib Chief Executive Officer | 2024-09-04 16:05:45 | 1,063,368 0 | 1,063,368 | Form 4 |
| LYNCH DANIEL Director | 2024-05-17 16:07:14 | 318,160 0 | 318,160 | Form 4 |
| Renstrup Jens Chief Medical Officer | 2021-01-11 09:30:41 | 299,099 0 | 299,099 | Form 4 |
| Smith L. Mary Chief Development Officer | 2024-01-08 21:13:06 | 293,363 0 | 293,363 | Form 4 |
| Greco Michael V. General Counsel & Secretary | 2019-09-12 16:29:46 | 246,975 0 | 246,975 | Form 3 |
| Edris Badreddin Chief Operating Officer | 2024-09-04 16:05:15 | 229,600 0 | 229,600 | Form 4 |
| Perier Francis I Jr Chief Financial Officer | 2024-01-08 21:11:34 | 119,253 0 | 119,253 | Form 4 |
| Weinstein Herschel S General Counsel & Secretary | 2024-01-08 21:13:31 | 112,239 0 | 112,239 | Form 4 |
| Pichl Daniel Chief People Officer | 2024-02-20 18:56:43 | 90,212 0 | 90,212 | Form 4 |
| Cassidy James Chief Medical Officer | 2024-09-03 16:05:26 | 73,856 0 | 73,856 | Form 4 |
| Nofi Michael Chief Accounting Officer | 2024-01-08 21:11:00 | 68,727 0 | 68,727 | Form 4 |
| Ashar Bhavesh Chief Commercial Officer | 2024-04-03 16:01:15 | 56,330 0 | 56,330 | Form 4 |
| Burgess Michael F. Head of Research & Development | 2022-07-20 18:02:22 | 49,584 0 | 49,584 | Form 4 |
| MACKAY MARTIN Director | 2024-07-30 16:10:34 | 39,408 0 | 39,408 | Form 4 |
| ALBAN CARLOS Director | 2024-05-17 16:01:41 | 31,017 0 | 31,017 | Form 4 |
| Lin Tai-An Chief Scientific Officer | 2024-10-03 16:26:20 | 26,965 0 | 26,965 | Form 4 |
| Fuhrman Alan Director | 2024-05-17 16:03:02 | 26,883 0 | 26,883 | Form 4 |
| Lewis-Hall Freda C Director | 2024-05-17 16:06:11 | 26,883 0 | 26,883 | Form 4 |
| Hambleton Julie Director | 2024-06-05 16:08:06 | 4,095 0 | 4,095 | Form 4 |
| PATRICK DEVAL L Director | 2019-09-12 16:36:08 | 0 0 | 0 | Form 3 |